Next drug patent cliff to challenge Big Pharma strategy
While the pharmaceutical market is expected to witness strong pricing competition, there is also significant opportunity for biotech companies, research says.
List view / Grid view
While the pharmaceutical market is expected to witness strong pricing competition, there is also significant opportunity for biotech companies, research says.
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...